Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Fed. Cir.

AngioScore, Inc. v. TriReme Medical, LLC, No. 16-1126 (Fed. Cir. Nov. 8, 2016)

Reversed in Part
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 16-1126
Also Docketed
No. 16-1142 (consolidated; same document)
Decided
November 8, 2016
Judge
Hughes, J.
Document
Nonprecedential Opinion
Length
9 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

AngioScore, Inc. sued the defendant -appellants ( Tri- Reme Medical, LLC , Quattro Vascular PTE Ltd., QT Vascular L td., and Eitan Konstantino ) for patent i n- fringement, breach of fiduciary duty, aiding and abetting, and unfair competition. After separate trials on the patent and state -law claims, the district court entered final judgment for Defendants on the patent claim , for AngioScore on the state-law claims, and denied Corporate Defendants’ (TriReme Medical, LLC , Quattro Vascular PTE Ltd., and QT V ascul…